Table 1.
Fatalities with buprenorphine or norbuprenorphine detected (n = 29) | Fatalities without buprenorphine or norbuprenorphine detected (n = 505) | p Value | ||||
---|---|---|---|---|---|---|
Age | Count | Percentage | Age | Count | Percentage | |
15–34 | 9 | 31.0% | 15–34 | 174 | 34.4% | 0.635 |
35–54 | 13 | 44.8% | 35–54 | 244 | 48.3% | |
55 + | 7 | 17.2% | 55 + | 87 | 17.2% | |
Sex | Count | Percentage | Sex | Count | Percentage | |
Male | 20 | 69.0% | Male | 369 | 73.1% | 0.629 |
Female | 9 | 31.0% | Female | 136 | 26.9% |
p values represent expected differences across all age categories